Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Adult Soft Tissue Sarcoma|Non Small Cell Lung Cancer|Triple Negative Breast Cancer|Colorectal Cancer|Biliary Tract Cancer
Interventions: DRUG: Ezabenlimab + BI907828
Sponsor: Institut Bergonié
Collaborators: Boehringer Ingelheim